Giraudo Bryan
Insider CIK 1740847 · PTGX Director · GOSS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 5,800,051 | — | $0 | 5,800,051 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 25 | $1000.00 | $25.0K | 25 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 5,800,051 | — | $0 | 5,800,051 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 25 | $1000.00 | $25.0K | 25 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-05-08 | 2026-05-11 | 6,000 | $100.00 | $600.0K | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-05-08 | 2026-05-11 | 5,130 | $100.00 | $513.0K | 12,695 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-05-07 | 2026-05-11 | 24,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-05-07 | 2026-05-11 | 12,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-05-07 | 2026-05-11 | 12,000 | $100.07 | $1.20M | 6,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-05-07 | 2026-05-11 | 36,000 | $100.14 | $3.61M | 27,825 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-05-07 | 2026-05-11 | 12,000 | $6.98 | $83.8K | 43,825 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-05-07 | 2026-05-11 | 24,000 | $6.45 | $154.8K | 31,825 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 96,667 | — | $0 | 96,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 47,667 | — | $0 | 47,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 176,667 | — | $0 | 176,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 211,500 | — | $0 | 211,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 211,500 | — | $0 | 211,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 181,250 | — | $0 | 181,250 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 543,750 | — | $0 | 543,750 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 638,000 | — | $0 | 638,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 693,750 | — | $0 | 693,750 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 96,667 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 47,667 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 60,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 100,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 176,667 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 211,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 211,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 181,250 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 543,750 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 638,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 693,750 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 693,750 | — | $0 | 693,750 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2026-01-02 | 2026-01-06 | 3,762 | — | $0 | 3,762 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2026-01-02 | 2026-01-05 | 115,750 | — | $0 | 389,737 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2026-01-02 | 2026-01-06 | 2,695 | — | $0 | 17,825 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2025-10-01 | 2025-10-02 | 181,250 | — | $0 | 273,987 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2025-03-04 | 2025-03-06 | 638,000 | — | $0 | 638,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2025-01-02 | 2025-01-06 | 6,584 | — | $0 | 6,584 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2025-01-02 | 2025-01-06 | 5,130 | — | $0 | 15,130 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2024-06-18 | 2024-06-20 | 100,000 | $0.59 | $59.0K | 480,010 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2024-03-27 | 2024-03-28 | 6,430 | $1.16 | $7.5K | 92,737 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 543,750 | — | $0 | 543,750 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2024-01-02 | 2024-01-04 | 25,700 | — | $0 | 25,700 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-11-20 | 2023-11-22 | 181,250 | — | $0 | 181,250 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2023-11-13 | 2023-11-14 | 200,000 | $0.56 | $112.0K | 380,010 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 13,505 | $0.13 | $1.8K | 13,505 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2023-07-24 | 2023-07-26 | 54,020 | $1.82 | $98.3K | 180,010 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 265,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 47,667 | — | $0 | 47,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 96,667 | — | $0 | 96,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 176,667 | — | $0 | 176,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 150,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 90,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 71,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 145,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2023-04-04 | 2023-04-05 | 55,000 | $1.02 | $56.1K | 125,990 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-03-20 | 2023-03-22 | 211,500 | — | $0 | 211,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2023-03-20 | 2023-03-22 | 50,000 | $0.97 | $48.5K | 70,990 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2023-01-16 | 2023-01-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2022-12-07 | 2022-12-09 | 211,500 | — | $0 | 211,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2022-07-15 | 2022-07-15 | 13,869 | $7.21 | $100.0K | 20,990 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2022-05-26 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2022-03-23 | 2022-03-24 | 10,722 | $8.92 | $95.6K | 99,167 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2022-01-06 | 2022-01-10 | 265,000 | — | $0 | 265,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2021-09-16 | 2021-09-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2021-05-27 | 2021-05-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2021-03-23 | 2021-03-25 | 5,490 | $9.48 | $52.0K | 109,889 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2021-02-25 | 2021-03-01 | 90,000 | — | $0 | 90,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2021-02-25 | 2021-03-01 | 45,000 | — | $0 | 115,379 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2020-10-14 | 2020-10-14 | 3,000 | $10.01 | $30.0K | 7,121 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2020-06-23 | 2020-06-23 | 2,000 | $12.96 | $25.9K | 4,121 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2020-05-28 | 2020-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 71,500 | — | $0 | 71,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2020-02-14 | 2020-02-19 | 46,500 | — | $0 | 70,379 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2019-12-03 | 2019-12-03 | 8,000 | $5.70 | $45.6K | 8,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2019-09-26 | 2019-09-26 | 1,121 | $16.78 | $18.8K | 2,121 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-06-07 | 2019-06-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2019-05-30 | 2019-06-03 | 1,000 | $18.70 | $18.7K | 1,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2019-03-25 | 2019-03-26 | 145,000 | — | $0 | 145,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 23,316 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 57,142 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2019-02-12 | 2019-02-12 | 6,000 | $16.00 | $96.0K | 23,879 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 17,879 | — | $0 | 17,879 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-05-29 | 2018-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-05-15 | 2018-05-17 | 24,000 | — | $0 | 24,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2017-05-16 | 2018-05-17 | 10,000 | $6.46 | $64.6K | 10,000 | SEC↗ |